Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Orgenesis Inc (ORGSD)

Orgenesis Inc (ORGSD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 45,310
  • Shares Outstanding, K 10,150
  • Annual Sales, $ 6,400 K
  • Annual Income, $ -9,190 K
  • 60-Month Beta N/A
  • Price/Sales 9.32
  • Price/Cash Flow N/A
  • Price/Book 4.04
Trade ORGSD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.7600 +61.74%
on 11/15/17
5.9500 -24.97%
on 12/12/17
+0.2640 (+6.29%)
since 11/10/17
3-Month
2.7600 +61.74%
on 11/15/17
7.8000 -42.77%
on 11/02/17
-0.3360 (-7.00%)
since 09/12/17
52-Week
2.7600 +61.74%
on 11/15/17
11.7600 -62.04%
on 04/03/17
-0.2160 (-4.62%)
since 12/12/16

Business Summary

Orgenesis, Inc. is a biopharmaceutical company. It focused on developing its trans-differentiation technologies for diabetes. The company deals with the combination of cell-based therapy and regenerative medicine into clinical development. Its operating segment consists of Contract Development and Manufacturing...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 6.4453
1st Resistance Point 5.4547
Last Price 4.4640
1st Support Level 3.9687
2nd Support Level 3.4733
3rd Support Level N/A

See More

52-Week High 11.7600
Fibonacci 61.8% 8.3220
Fibonacci 50% 7.2600
Fibonacci 38.2% 6.1980
Last Price 4.4640
52-Week Low 2.7600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar